ID   CRTC2_RAT               Reviewed;         691 AA.
AC   Q3LRZ1;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2005, sequence version 1.
DT   07-APR-2021, entry version 96.
DE   RecName: Full=CREB-regulated transcription coactivator 2;
DE   AltName: Full=Transducer of regulated cAMP response element-binding protein 2;
DE            Short=TORC-2;
DE            Short=Transducer of CREB protein 2;
GN   Name=Crtc2; Synonyms=Torc2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Wu H., Miao S., Shen H., Xiong Z.;
RT   "TORC2 in central nervous system.";
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-611, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Transcriptional coactivator for CREB1 which activates
CC       transcription through both consensus and variant cAMP response element
CC       (CRE) sites. Acts as a coactivator, in the SIK/TORC signaling pathway,
CC       being active when dephosphorylated and acts independently of CREB1
CC       'Ser-133' phosphorylation. Enhances the interaction of CREB1 with TAF4.
CC       Regulates gluconeogenesis as a component of the LKB1/AMPK/TORC2
CC       signaling pathway. Regulates the expression of specific genes such as
CC       the steroidogenic gene, StAR. Potent coactivator of PPARGC1A and
CC       inducer of mitochondrial biogenesis in muscle cells (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: Binds, as a tetramer, through its N-terminal region, with the
CC       bZIP domain of CREB1. 'Arg-314' in the bZIP domain of CREB1 is
CC       essential for this interaction. Interaction, via its C-terminal, with
CC       TAF4, enhances recruitment of TAF4 to CREB1. Interacts with SIK2.
CC       Interacts with 14-3-3 proteins, YWHAB and YWHAG. Interacts (probably
CC       when phosphorylated at Ser-171) with YWHAE. Interacts with calmodulin-
CC       dependent catalytic subunit PPP3CA/calcineurin A (By similarity).
CC       Interaction with COP1 mediates nuclear export and degradation of CRTC2
CC       (By similarity). {ECO:0000250|UniProtKB:Q3U182,
CC       ECO:0000250|UniProtKB:Q53ET0}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q53ET0}. Nucleus
CC       {ECO:0000250|UniProtKB:Q53ET0}. Note=Translocated from the nucleus to
CC       the cytoplasm on interaction of the phosphorylated form with 14-3-3
CC       protein. In response to cAMP levels and glucagon, relocated to the
CC       nucleus. {ECO:0000250|UniProtKB:Q53ET0}.
CC   -!- PTM: Phosphorylation/dephosphorylation states of Ser-171 are required
CC       for regulating transduction of CREB activity. CRTCs/TORCs are inactive
CC       when phosphorylated, and active when dephosphorylated at this site.
CC       This primary site of phosphorylation, is regulated by cAMP and calcium
CC       levels and is dependent on the phosphorylation of SIKs (SIK1 and SIK2)
CC       by LKB1 (By similarity). Following adenylyl cyclase activation,
CC       dephosphorylated at Ser-171 by PPP3CA/calcineurin A resulting in CRTC2
CC       dissociation from 14-3-3 proteins and PPP3CA (By similarity). Both
CC       insulin and AMPK increase this phosphorylation of CRTC2 while glucagon
CC       suppresses it. Phosphorylation at Ser-274 by MARK2 is induced under low
CC       glucose conditions and dephosphorylated in response to glucose influx.
CC       Phosphorylation at Ser-274 promotes interaction with 14-3-3 proteins
CC       and translocation to the cytoplasm (By similarity).
CC       {ECO:0000250|UniProtKB:Q3U182, ECO:0000250|UniProtKB:Q53ET0}.
CC   -!- PTM: Asymmetric dimethylation of arginine resisues by PRMT6 enhances
CC       the association of CRTC2 with CREB on the promoters of gluconeogenic
CC       genes. {ECO:0000250|UniProtKB:Q3U182}.
CC   -!- SIMILARITY: Belongs to the TORC family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ185515; ABA28301.1; -; mRNA.
DR   RefSeq; NP_001029067.1; NM_001033895.1.
DR   SMR; Q3LRZ1; -.
DR   BioGRID; 259674; 3.
DR   STRING; 10116.ENSRNOP00000021700; -.
DR   iPTMnet; Q3LRZ1; -.
DR   PhosphoSitePlus; Q3LRZ1; -.
DR   jPOST; Q3LRZ1; -.
DR   PaxDb; Q3LRZ1; -.
DR   PRIDE; Q3LRZ1; -.
DR   Ensembl; ENSRNOT00000092144; ENSRNOP00000068813; ENSRNOG00000056337.
DR   GeneID; 310615; -.
DR   KEGG; rno:310615; -.
DR   UCSC; RGD:1308903; rat.
DR   CTD; 200186; -.
DR   RGD; 1308903; Crtc2.
DR   eggNOG; ENOG502QVWA; Eukaryota.
DR   GeneTree; ENSGT00390000010652; -.
DR   HOGENOM; CLU_019357_1_0_1; -.
DR   InParanoid; Q3LRZ1; -.
DR   OMA; RHIIDSS; -.
DR   OrthoDB; 1118500at2759; -.
DR   PhylomeDB; Q3LRZ1; -.
DR   PRO; PR:Q3LRZ1; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000056337; Expressed in spleen and 21 other tissues.
DR   ExpressionAtlas; Q3LRZ1; baseline and differential.
DR   Genevisible; Q3LRZ1; RN.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0008140; F:cAMP response element binding protein binding; IBA:GO_Central.
DR   GO; GO:0003682; F:chromatin binding; IDA:RGD.
DR   GO; GO:0006094; P:gluconeogenesis; ISS:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; IMP:RGD.
DR   GO; GO:0043970; P:histone H3-K9 acetylation; ISO:RGD.
DR   GO; GO:0032793; P:positive regulation of CREB transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0051289; P:protein homotetramerization; IEA:InterPro.
DR   GO; GO:1901998; P:toxin transport; ISO:RGD.
DR   InterPro; IPR024786; TORC.
DR   InterPro; IPR024785; TORC_C.
DR   InterPro; IPR024784; TORC_M.
DR   InterPro; IPR024783; TORC_N.
DR   PANTHER; PTHR13589; PTHR13589; 1.
DR   Pfam; PF12886; TORC_C; 1.
DR   Pfam; PF12885; TORC_M; 1.
DR   Pfam; PF12884; TORC_N; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Cytoplasm; Isopeptide bond; Methylation; Nucleus;
KW   Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   CHAIN           2..691
FT                   /note="CREB-regulated transcription coactivator 2"
FT                   /id="PRO_0000318530"
FT   MOTIF           271..287
FT                   /note="Nuclear export signal"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        236..240
FT                   /note="Poly-Ser"
FT   COMPBIAS        336..412
FT                   /note="Ser-rich"
FT   SITE            627
FT                   /note="Required for ubiquitination and degradation"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         51
FT                   /note="Asymmetric dimethylarginine; by PRMT6"
FT                   /evidence="ECO:0000250|UniProtKB:Q3U182"
FT   MOD_RES         70
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         86
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         90
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         99
FT                   /note="Asymmetric dimethylarginine; by PRMT6"
FT                   /evidence="ECO:0000250|UniProtKB:Q3U182"
FT   MOD_RES         120
FT                   /note="Asymmetric dimethylarginine; by PRMT6"
FT                   /evidence="ECO:0000250|UniProtKB:Q3U182"
FT   MOD_RES         123
FT                   /note="Asymmetric dimethylarginine; by PRMT6"
FT                   /evidence="ECO:0000250|UniProtKB:Q3U182"
FT   MOD_RES         136
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         161
FT                   /note="Asymmetric dimethylarginine; by PRMT6"
FT                   /evidence="ECO:0000250|UniProtKB:Q3U182"
FT   MOD_RES         168
FT                   /note="Asymmetric dimethylarginine; by PRMT6"
FT                   /evidence="ECO:0000250|UniProtKB:Q3U182"
FT   MOD_RES         169
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3U182"
FT   MOD_RES         171
FT                   /note="Phosphoserine; by AMPK, MARK2, SIK1 and SIK2"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         192
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         274
FT                   /note="Phosphoserine; by MARK2"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         306
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         368
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         393
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         433
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         456
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         488
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         489
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         492
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         501
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   MOD_RES         611
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         621
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3U182"
FT   MOD_RES         622
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
FT   CROSSLNK        234
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q53ET0"
SQ   SEQUENCE   691 AA;  73146 MW;  8CC1DA5B06D890B0 CRC64;
     MATSGANGPG SATASASNPR KFSEKIALQK QRQAEETAAF EEVMMDIGST RLQAQKLRLA
     YTRSSHYGGS LPNVNQIGCG LAEFQSPLHS PLDSSRSTRH HGLVERVQRD PRRMVSPLRR
     YPRHIDSSPY SPAYLSPPPE SGWRRMMPWG NLPAEKGQLF RLPSALNRTS SDSALHTSVM
     NPNPQDTYPG PTPPSVLPSR RGGFLDGEMD AKVPAIEENL VDDKHLLKPW DAKKLSSSSS
     RPRSCEVPGI NIFPSPDQPA NVPVLPPAMS TGGSLPDLTN LHFPPPLPTP LDPEETVYPS
     LSGGNSTTNL THTMTHLGIS GGLGLGPSYD VPGLHSPLSH PSLQSSLSNP NLQASLSSPQ
     PQLQGSHSHP SLPASSLAHH ALPTTSLGHP SLSAPALSSS SSSSSTSSPV LSAPPYPAST
     PGASPRHRRV PLSPLSLPAG PADARRSQQQ LPKQFSPTMS PTLSSITQGV PLDTSKLPTD
     QRLPPYPYSP PSLVIPSHPP TPKSLQQLPS QACLVQPSGG QPPGRQPHYG TLYPPGSSGH
     GQQPYHRPIN DFSLGNLEQF NMESPSTSLV LDPPAFSEGP GFLGSEGSVS GPQDSHVLNH
     QNLTHCSRHG SGPNIILTGD SSPGFSKEIA AALAGVPGFE VSASGLELGL GLEDELRMEP
     LGLEGLTMLS DPCALLPDPA VEDSFRSDRL Q
//
